In 41 children with house dust mite allergic rhinitis, with or without asthma, 14 weeks of weekly subcutaneous immunotherapy reduced total IgE, TGF-β1, symptom-medication and VAS scores from baseline; specific IgE and IL-10 changes were non-significant.
RCTn = 41
Putera et al. Subcutaneous immunotherapy with house dust mite extract in Indonesian children with allergic rhinitis and asthma: A double-blind randomized controlled trial